Advertisement

Ads Placeholder
Loading...

Molecule Holdings Inc.

ERV2.FXETRA
Healthcare
Drug Manufacturers - Specialty & Generic
0.001
0.00(0.00%)
German Market opens in 1h 37m

Molecule Holdings Inc. (ERV2.F) Stock Overview

Explore Molecule Holdings Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap329.9K
P/E Ratio-0.02
EPS (TTM)$-0.03
ROE2.97%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ERV2.F Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Molecule Holdings Inc. (ERV2.F) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.02 and a market capitalization of 329.9K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
-92.86%
3-Year Change
-99.49%
5-Year Change
-98.87%
All-Time (Max) Change
-98.87%

Contact Information

NaN
591 Reynolds Road, Lansdowne, ON, K0E 1L0

Company Facts

IPO DateSep 24, 2020
CountryCA

Frequently Asked Questions